DE3071651D1 - The use of ricin and a pharmaceutical composition containing the same for increasing the immune response - Google Patents

The use of ricin and a pharmaceutical composition containing the same for increasing the immune response

Info

Publication number
DE3071651D1
DE3071651D1 DE8080106852T DE3071651T DE3071651D1 DE 3071651 D1 DE3071651 D1 DE 3071651D1 DE 8080106852 T DE8080106852 T DE 8080106852T DE 3071651 T DE3071651 T DE 3071651T DE 3071651 D1 DE3071651 D1 DE 3071651D1
Authority
DE
Germany
Prior art keywords
ricin
increasing
pharmaceutical composition
same
immune response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8080106852T
Other languages
German (de)
English (en)
Inventor
Hiroshi Shionoya
Haruyoshi Arai
Nozomu Koyanagi
Hitoshi Takeuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE3071651D1 publication Critical patent/DE3071651D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8080106852T 1979-11-09 1980-11-06 The use of ricin and a pharmaceutical composition containing the same for increasing the immune response Expired DE3071651D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14432779A JPS5668615A (en) 1979-11-09 1979-11-09 Ricin-containing agent for immunological enhancement

Publications (1)

Publication Number Publication Date
DE3071651D1 true DE3071651D1 (en) 1986-07-24

Family

ID=15359522

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8080106852T Expired DE3071651D1 (en) 1979-11-09 1980-11-06 The use of ricin and a pharmaceutical composition containing the same for increasing the immune response

Country Status (6)

Country Link
US (1) US4459287A (enExample)
EP (1) EP0028815B1 (enExample)
JP (1) JPS5668615A (enExample)
DE (1) DE3071651D1 (enExample)
FR (1) FR2469711A1 (enExample)
IT (1) IT1134188B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57197223A (en) * 1981-05-27 1982-12-03 Eisai Co Ltd Immunoenhancing agent containing ricin b chain
JPS61165334A (ja) * 1984-08-03 1986-07-26 メデイサ−チ、エス、ア− ウイルスの感染活性の抑制方法および組成物
JPH0825890B2 (ja) * 1987-06-18 1996-03-13 呉羽化学工業株式会社 抗ウイルス剤
KR950009099B1 (ko) * 1992-06-23 1995-08-14 한영복 항후천성면역결핍증바이러스효과를갖는생약추출조성물및그추출방법
US5453271A (en) * 1993-06-28 1995-09-26 The United States Of America As Represented By The Secretary Of The Army Vaccine against ricin toxin
US5667786A (en) * 1995-06-07 1997-09-16 Novavax, Inc. Method for treating tumors with a toxin
EP2065052A3 (en) * 2000-08-30 2009-08-19 Pfizer Products Inc. Anti-IgE vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3060165A (en) * 1962-10-23 Preparation of toxic ricin
GB1522600A (en) * 1975-12-01 1978-08-23 Boehringer Sohn Ingelheim Proteins
JPS5344613A (en) * 1976-09-30 1978-04-21 Eisai Co Ltd Tumor vaccine containing lectin/tumor cell-complex

Also Published As

Publication number Publication date
IT8025834A0 (it) 1980-11-07
JPS5668615A (en) 1981-06-09
IT1134188B (it) 1986-07-31
EP0028815A2 (en) 1981-05-20
FR2469711B1 (enExample) 1984-10-19
EP0028815A3 (en) 1982-03-10
US4459287A (en) 1984-07-10
EP0028815B1 (en) 1986-06-18
FR2469711A1 (fr) 1981-05-22
JPS6236501B2 (enExample) 1987-08-07

Similar Documents

Publication Publication Date Title
GB2103591B (en) Pharmaceutical compositions and process
NZ189378A (en) 4-amino-5-alkylsulphonyl-ortho-anisamdes and pharmaceutical compositions
NZ190784A (en) Benzofuranyl-piperidines and pharmaceutical compositions
NZ193798A (en) 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions
CS396791A3 (en) Synthetic peptides and pharmaceutical compositions containing thereof
GB2046259B (en) Amino-alcohol derivatives and pharmaceutical compositions containing them
PH16443A (en) Substituted tetraazetricyclic compounds and their pharmaceutical compositions
NZ194348A (en) Fluorinated methyl-beta-alanine derivatives and pharmaceutical compositions
IL61117A0 (en) Acetoxymethyl-penem compounds and pharmaceutical compositions containing them
IL60376A (en) 3-diphenylmethyleneazetidines and pharmaceutical compositions containing them
GB2048671B (en) Pharmaceutical composition containing dihydroegotoxine
IL57476A0 (en) Compounds of the muramy-peptide type and pharmaceutical compositions containing them
DE3277171D1 (en) Pharmaceutical composition and the use of sn- or cr-protoporphyrin for the manufacture thereof
NZ189899A (en) Dilignols and dilignol-type compounds pharmaceutical compositions
IL59177A0 (en) Spiro-quinolylhydantoins and pharmaceutical compositions containing them
PH16220A (en) Pyrro-lidine derivatives and pharmaceutical compositions thereof
GB2048250B (en) 2-amino-6-aryl-4-pyrimidinols and their pharmaceutical uses
IL57882A (en) 2-thiophenecarboxamido-alkyl-mercaptans and pharmaceutical compositions containing them
NZ189279A (en) Arylaminoimidazolines and pharmaceutical compositions
IL60695A (en) Hexahydro-trans-pyridoindole-alkanamine derivatives and pharmaceutical compositions containing them
NZ190293A (en) Benzimidoyl-piperazines and pharmaceutical compositions
NZ189703A (en) N'-glucofuranosid-6-yl-n3-nitroso-ureas and pharmaceutical compositions
IL60332A0 (en) Pyridylaminotriazole derivatives and pharmaceutical compositions containing them
IL61038A (en) 15-sulfonamidoprostaglandin derivatives and pharmaceutical compositions containing them
GB2021588B (en) Bibenzyl derivatives the preparation thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee